Jeito Capital co-leads EUR 80 million Series B financing in European oncology company, Precirix
Jeito Capital co-leads EUR 80 million Series B financing in European oncology company, Precirix Jeito Capital chooses Precirix, a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology as its ninth investment. The financing will allow Precirix to advance its pipeline of precision radiopharmaceuticals. Paris, France, 16 March 2022 – Jeito Capital (“Jeito”), a leading independent […]